M11.111
Familial chondrocalcinosis, right shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Familial chondrocalcinosis, also known as calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, is a condition characterized by the accumulation of calcium crystals in the cartilage of joints. When this occurs specifically in the right shoulder, it can lead to joint discomfort and limited mobility. This condition can be inherited, meaning it runs in families, and is often associated with other metabolic or genetic disorders. Recognizing this condition early can help manage symptoms and improve quality of life.
Causes & Symptoms
Clinical Causes: Genetic predisposition: Inherited traits that increase the likelihood of crystal deposition in joints. Metabolic disorders: Conditions such as hyperparathyroidism, hemochromatosis, or hypothyroidism can contribute to calcium crystal formation. Aging: The risk increases with age, as cartilage becomes more susceptible to crystal deposits. Joint trauma or injury: Previous injuries may predispose joints to crystal accumulation. Other joint diseases: Pre-existing osteoarthritis can facilitate crystal deposition.
Key Symptoms: Joint pain, especially during movement or after periods of inactivity Swelling and inflammation around the shoulder joint Reduced range of motion in the affected shoulder Tenderness when touching the shoulder Possible flare-ups with sudden worsening of symptoms A sensation of stiffness or weakness in the joint
Diagnostic & Treatment
Diagnosis Path: Diagnosing familial chondrocalcinosis involves a combination of clinical assessment and laboratory tests. Healthcare providers often conduct a physical examination, noting signs of joint swelling or tenderness. Imaging studies, such as X-rays, can reveal calcification within the shoulder cartilage characteristic of this condition. Additionally, joint fluid analysis via arthrocentesis can detect calcium crystals, confirming the diagnosis. Blood tests may be performed to identify underlying metabolic issues, such as elevated calcium or iron levels.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate pain and reduce inflammation Corticosteroid injections directly into the shoulder joint for severe flare-ups Physical therapy to maintain joint mobility and strengthen surrounding muscles Lifestyle modifications including weight management and activity adjustments Management of underlying metabolic conditions that contribute to crystal formation Use of analgesics for pain relief when necessary
Clinical Advice & FAQs
Billing Guidance
Is M11.111 a billable ICD-10 code?
Yes, M11.111 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.111?
Clinical documentation must specify the nature of Familial chondrocalcinosis, right shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference